Ajooni Biotech Ltd

- Navigant Corporate Advisors Ltd

Public issue of 21,96,000 equity shares of face value of Rs. 10 each (equity shares) of Ajooni Biotech Limited (the company or the issuer) for cash at a price of Rs. 30 per equity share, including a share premium of Rs. 20 per equity share (the issue price), aggregating Rs. 6.59 Crores (the issue), of which 1,12,000 equity shares of face value of Rs. 10 each for cash at a price of Rs. 30 per equity share, aggregating Rs. 0.34 Crores will be reserved for subscriptions by the market maker to the issue (the market maker reservation portion). The issue less market maker reservation portion i.e. Issue of 20,84,000 equity shares of face value of Rs.10 each cash at a price of Rs. 30 per equity share, aggregating Rs. 6.25 Crores is hereinafter referred to as the net issue. The issue and the net issue will constitute 37.51% and 35.59% respectively of the post issue paid up equity share capital of the company.The face value of the equity shares is Rs.10 each and the issue price is Rs.30 each i.e. 3.00 times of the face value.

  • Issue

    • Opens On20 Dec 2017
    • Closes On22 Dec 2017
  • Money Payable On

    • Application30
    • Allotment0
  • Project Cost (Cr.)6.59
  • Post Issue Equity Share Capital (Cr.)5.86
  • Issue Price (D)30

Further Multiples of: 4000

Projects

  • Promoted By
    • Listing At - NSE - SME
    • Registrar to the Issue - Cameo Corporate Services Ltd

    D-118 Industrial Area Phase-7 Mohali

    Punjab- 160059

    Phone - 91-172-5020758-69

    Fax -

    Email - info@ajoonibiotech.com

    Website - www.ajoonibiotech.com

    angle-up